Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Grisendi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oncogene|May 29, 2002
Modelling haematopoietic malignancies in the mouse and therapeutical implicationsRosa Bernardi, Silvia Grisendi, Pier Paolo Pandolfi
Nature Reviews. Cancer|June 24, 2006
Nucleophosmin and cancerSilvia Grisendi, Cristina Mecucci, Brunangelo Falini, et al.
Nature|July 12, 2005
Role of nucleophosmin in embryonic development and tumorigenesisSilvia Grisendi, Rosa Bernardi, Marco Rossi, et al.
Science (New York, N.Y.)|January 11, 2003
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modificationDavide Ruggero, Silvia Grisendi, Francesco Piazza, et al.
Blood|January 24, 2008
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mousePaolo Sportoletti, Silvia Grisendi, Samia M Majid, et al.
Molecular and Cellular Biology|September 24, 2008
Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosomeLeonard B Maggi, Michael Kuchenruether, David Y A Dadey, et al.
Nature|August 18, 2006
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTORRosa Bernardi, Ilhem Guernah, David Jin, et al.
Nature Genetics|October 2, 2019
Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenitaDaphna Nachmani, Anne H Bothmer, Silvia Grisendi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncogene|May 29, 2002
Modelling haematopoietic malignancies in the mouse and therapeutical implicationsRosa Bernardi, Silvia Grisendi, Pier Paolo Pandolfi
Nature Reviews. Cancer|June 24, 2006
Nucleophosmin and cancerSilvia Grisendi, Cristina Mecucci, Brunangelo Falini, et al.
Nature|July 12, 2005
Role of nucleophosmin in embryonic development and tumorigenesisSilvia Grisendi, Rosa Bernardi, Marco Rossi, et al.
Science (New York, N.Y.)|January 11, 2003
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modificationDavide Ruggero, Silvia Grisendi, Francesco Piazza, et al.
Blood|January 24, 2008
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mousePaolo Sportoletti, Silvia Grisendi, Samia M Majid, et al.
Molecular and Cellular Biology|September 24, 2008
Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosomeLeonard B Maggi, Michael Kuchenruether, David Y A Dadey, et al.
Nature|August 18, 2006
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTORRosa Bernardi, Ilhem Guernah, David Jin, et al.
Nature Genetics|October 2, 2019
Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenitaDaphna Nachmani, Anne H Bothmer, Silvia Grisendi, et al.
Pageof 1